SeekingAlpha · Mar 6, 2026
NYSE · BME
BlackRock Health Sciences Trust
Financial Services · Asset Management
$44.22
Up+$0.24 (+0.54%)
Updated Sep 14, 2026, 7:42 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 523.23M
- P/E ratio
- 8.62
- Dividend yield
- 7.11%
- 52-week range
- $37.51 – $46.43
- Volume
- 20.7K
- Avg. volume
- 50.34K
Price performance
BME price history
1M range · 19 trading sessions · Daily adjusted prices
BME closed at $44.22 after 19 trading sessions, down 0.41% for the selected period.
- Last close
- $44.22
- Period change
- -0.41%
- Period low
- $44.06
- Period high
- $46.28
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $44.47 | $44.6799 | $44.20 | $44.22 | 20.7K |
| Sep 10, 2026 | $44.32 | $44.55 | $44.00 | $44.06 | 38.8K |
| Sep 9, 2026 | $44.96 | $44.96 | $44.26 | $44.35 | 35.52K |
| Sep 8, 2026 | $45.54 | $45.54 | $44.75 | $45.05 | 63.5K |
| Sep 4, 2026 | $45.63 | $45.97 | $45.5001 | $45.81 | 35.26K |
| Sep 3, 2026 | $45.89 | $46.1638 | $45.68 | $46.01 | 27.17K |
| Sep 2, 2026 | $45.60 | $46.27 | $45.60 | $45.80 | 46.65K |
| Sep 1, 2026 | $45.60 | $46.21 | $45.53 | $45.62 | 42.13K |
| Aug 31, 2026 | $45.91 | $45.91 | $45.38 | $45.59 | 47.64K |
| Aug 28, 2026 | $46.15 | $46.15 | $45.65 | $45.88 | 41K |
| Aug 27, 2026 | $46.10 | $46.35 | $45.80 | $46.10 | 54.02K |
| Aug 26, 2026 | $46.35 | $46.40 | $46.08 | $46.28 | 42.15K |
| Aug 25, 2026 | $45.84 | $46.425 | $45.6501 | $46.19 | 49.03K |
| Aug 24, 2026 | $46.26 | $46.26 | $45.65 | $45.81 | 34.44K |
| Aug 21, 2026 | $45.72 | $46.3751 | $45.71 | $46.13 | 61.47K |
| Aug 20, 2026 | $45.74 | $46.1699 | $45.64 | $45.80 | 68.19K |
| Aug 19, 2026 | $45.20 | $45.72 | $45.00 | $45.63 | 47.8K |
| Aug 18, 2026 | $44.64 | $44.98 | $44.50 | $44.86 | 35.26K |
| Aug 17, 2026 | $44.11 | $44.45 | $44.10 | $44.40 | 23.88K |
Latest BME news
The latest Smart Investors Daily articles mentioning BME.
Stock researchCompany · Overview
BME research
Overview
Company profile and research snapshot.
Company profile
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Jan 22, 2026
Switching From THQ To BME Despite The Yield
Shift from THQ to BME: THQâs 11% yield faces leverage, ROC, and NAV erosion risks. Click here to read what investors need to know.
SeekingAlpha · Jan 20, 2026
BSTZ: High Growth Potential With Monthly Income, 11% Discount To NAV
SeekingAlpha · Jan 14, 2026
XLV Vs. BME: Total Return Or Income, Which Healthcare Strategy Wins?
Explore why Health Care may mean-revert in 2026. Compare XLV vs BME yields, valuation and NAV discount, plus key risks.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
